The Biotechnology Instruments Market is Estimated to Witness High Growth Owing to Opportunity of Advancing Research Across Industries

Mia Yates

The Biotechnology Instruments Market is Estimated to Witness High Growth Owing to Opportunity of Advancing Research Across Industries

Biotechnology instruments aid in performing various tasks across industries like medical, biotechnology, pharma, environmental, and industrial biotech sectors. These instruments are used for DNA and protein microarray, cell culture analysis, lab automation, chromatography, gel documentation, and electrophoresis, among others. Growing focus on advancing drug discovery, protein therapeutics, and stem cell research has augmented the need for accurate and efficient biotechnology tools. The global Biotechnology Instruments Market is estimated to be valued at US$ 57 Bn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The opportunity of advancing research across industries will drive the biotechnology instruments market growth over the forecast period. Growing funding in biotechnology sector, expanding application of nanotechnology and proteomics along with rising R&D activities are augmenting advanced research in the medical, pharmaceutical, chemical, and agro-biotech domains. Biotechnology tools are playing a crucial role in expediting research processes across industries. Advancements in technologies will further aid researchers in discovering new molecular targets, biomarkers and developing customized therapies. Growing collaborations between industry players and research institutes to develop innovative tools and assays are also supporting market growth. Companies are launching novel platforms to cater to the rising demand from research organizations and academic institutes. This advancing research landscape will continue augmenting the demand for accurate, high-throughput and automated biotechnology instruments in the coming years.

Porter's Analysis

Threat of new entrants: The biotechnology instruments market requires significant capital investment and R&D expenditure for production of specialized equipment. This poses high entry barriers for new players.

Bargaining power of buyers: Buyers in the market have moderate bargaining power due to availability of substitutes and presence of several instrument manufacturers. However, specialized nature of equipment limits impact of bargaining power.

Bargaining power of suppliers: Key components suppliers have moderate bargaining power due to availability of substitute suppliers and dependence of instrument makers on suppliers.

Threat of new substitutes: Threat of substitution is low as biotechnology instruments have no close substitute and are specialized for specific applications in research and production.

Competitive rivalry: The market sees high competition due to presence of numerous global and regional players offering similar product ranges. Players compete on technology, quality, reliability, services and pricing.

SWOT Analysis

Strengths: Large market size and high global demand for biotechnology products drive significant opportunities. Major players have strong R&D and manufacturing capabilities.

Weaknesses: Significant capital requirements pose challenges for small players and market entry. Customized requirements increase service and maintenance costs for instruments.

Opportunities: Emerging markets in Asia Pacific and Latin America present new growth prospects. Increasing knowledge and access to biologics widens application scope.

Threats: Stringent regulatory norms increase compliance burden. Economic slowdowns impact product demand and investment in the sector. Intense competition increases pricing pressure.

Key Takeaways

The Global Biotechnology Instruments Market Size is expected to witness high growth over the forecast period driven by rising demand for biologics and biotechnology research activities.

Regional analysis: Asia Pacific is projected to witness the highest growth during the forecast period. Countries such as China, India, Japan and South Korea are emerging as attractive destinations for outsourcing of biotechnology research and production. This is expected to drive higher adoption of advanced biotech instruments in the region.

Key players operating in the biotechnology instruments market are Kawasumi Laboratories Inc., Blood Purification Technologies Inc., AWAK Technologies Pte. Ltd, Triomed AB, Asahi Kasei Medical Vo. Ltd, US Kidney Research Corporation, Merit Medical Systems, NIPRO Medical Corporation, Fresenius SE & Co. KGaA. Major players are focusing on new product launches, acquisitions and geographical expansion to strengthen their market position.

For More Insights, Read: https://www.newswirestats.com/biotechnology-instruments-market-demand-growth-and-regional-outlook-by-2030/

Mia Yates

Biotechnology Instruments Market Growth Accelerated by Adoption of Technologies

ashwinicmi 2024-01-08

The global Biotechnology Instruments Market is estimated to be valued at US$ 57. Emerging technologies are thus expected to transform the biotechnology instruments market over the forecast period. Segment AnalysisThe global biotechnology instruments market is dominated by the nanotechnology sub-segment. Nanotechnology in biotechnology instruments involves the development and use of devices and materials such as nanoparticles, nanopores, nanotubes and nanolithography for applications in biotechnology. Key TakeawaysThe global biotechnology instruments market is expected to witness high growth over the forecast period of 2023 to 2030.

Global Biotechnology Instruments Market Is Estimated To Witness High Growth Owing To Innovations in Research and Increasing Funding for Biotechnology Research

Ben Wood 2023-10-18

SWOT Analysis:Strength: The biotechnology instruments market is expected to witness high growth, with a CAGR of 9. 4% over the forecast period. Weakness: One weakness in the biotechnology instruments market is the high cost associated with these instruments. Threats: Two threats in the biotechnology instruments market are the stringent regulatory requirements and the ethical concerns associated with certain biotechnology applications. Key Takeaways:The global biotechnology instruments market is expected to witness high growth, exhibiting a CAGR of 9. 4% over the forecast period.

Biotechnology Market Growth Accelerated by Emerging Markets Adoption

Mia Yates 2024-01-31

The Global Biotechnology Market Size is estimated to be valued at US$ 945. Segment Analysis The global biotechnology market is segmented into DNA/gene-based technologies, medical devices, cell and tissue-based technologies, nanotechnology-based tools and platforms, and analytical and laboratory technologies segments. Amongst all the segments, the DNA/gene-based technologies dominates the global biotechnology market. Regional analysis: North America region dominates the global biotechnology market currently. This is credited to rising prevalence of chronic and genetic diseases, growing geriatric population, increasing biotechnology research activities, and growing presence of global key biotechnology companies in the region.

Global Biotechnology Market Is Estimated To Witness High Growth

Larry Paige 2023-08-29

The global Biotechnology Market is estimated to be valued at US$ 820. B) Market Key Trends: One key trend in the biotechnology market is the rapid adoption of gene editing technologies. C) PEST Analysis: - Political: Government regulations and policies play a crucial role in shaping the biotechnology market. D) Key Takeaways: - The global biotechnology market is expected to witness high growth, exhibiting a CAGR of 12. - Key players operating in the global biotechnology market include Abbott Laboratories, Amgen Inc.

Ultramodern Biotechnology is Estimated to Witness High Growth Owing to Opportunity to Address Unmet Medical Needs

Sumedha 2024-01-18

The global biotechnology market is estimated to be valued at US$ 820. Another driver augmenting market growth is increasing adoption of biotechnology in agricultural applications for development of genetically modified seeds, crops tolerant to herbicides. Weakness: High investment requirements are one of the major weaknesses of the biotechnology market. Key TakeawaysThe Global Biotechnology Market Size is expected to witness high growth over the forecast period of 2023 to 2030. Regional analysis: North America currently dominates the biotechnology market, owing to high healthcare spending and presence of major players in the region.

Brief Analysis on Biotechnology Instruments Market 2021 Industry Trends and Future Growth Predictions | Key Players like Abbott,Agilent Technologies,Alcon, Inc.,AngioDynamics

krishna 2021-11-12

Biotechnology Instruments Market size is projected to reach USD 59.6 Billion by 2027 from an estimated USD 41 Billion in 2020, growing at a CAGR of 5.4% globally.

Approximately 6,000 years ago, humans utilized the biological methods of microorganisms to make alcoholic beverages, bread, cheese, and to preserve dairy products.

This report categorizes the market broadly by categorizing the market by Application, Type, and Geographic Region.

This study provides insights into the impact of global and local market experts, value chain optimization, probabilistic research, technical objectives, product launches, and critical market growth reviews.Key Prominent Players In The Biotechnology Instruments Market:Abbott,Agilent Technologies,Alcon, Inc.,AngioDynamics,Becton, Dickinson, and Company,BioMerieux SA,Bio-Rad Laboratories,BioTek Instruments, Inc.,Candela Medical,Cynosure, LLC,Danaher Corporation,Endress+Hauser (Analytik Jena GmbH),F. Hoffmann-La Roche Ltd.,IIlumina Inc. MedizinSysteme Know More About The Global Trends Impacting The Future, Download A PDF Sample@:https://www.introspectivemarketresearch.com/request/15976The research reports on the Global Biotechnology Instruments Market 2021 cover all the large regions, not just the small regions around the world.

The report focused on market size, value, product sales and growth opportunities in the region.

In addition to providing valuable insights into customers and industries, market research also analyzed competitiveness.

WHO TO FOLLOW

MORE FROM AUTHOR

Beyond Classical Limits: Quantum Key Distribution as the Pinnacle of Secure Communication

Mia Yates 2024-02-26

Pyrethroids in Agriculture: Balancing Efficacy, Safety, and Environmental Sustainability

Mia Yates 2024-02-26

The Smallpox Treatment Market Will Grow At Highest Pace Owing To Rising Investment In Vaccine Development And Production

Mia Yates 2024-02-26

Robot Suitcase Market Will Grow At Highest Pace Owing To Increasing Demand For Medical Mobility Among Aged Population

Mia Yates 2024-02-26

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Red Biotechnology Market Growth Accelerated by Expanded Application Areas

Rajkumar cmi 2024-02-08

The red biotechnology market incorporates diagnostics and therapeutic technologies used for the treatment and diagnosis of diseases. The global red biotechnology Market is estimated to be valued at US$ 855. The increasing adoption of personalized medicine approach can significantly drive the growth of the red biotechnology market during the forecast period. Porter's Analysis Threat of new entrants: The red biotechnology market size is capital-intensive requiring large investments in R&D. Regional analysis: The Asia Pacific region is set to witness the highest growth in the red biotechnology market during the forecast period.

Animal Biotechnology Market Growth Accelerated by Developing New Therapies

Ishika cmi 2024-02-09

The global Animal Biotechnology Market is estimated to be valued at US$ 27. Additionally, animal biotechnology is being leveraged to develop new vaccines and therapies for various animal diseases. Segment Analysis The global animal biotechnology market is dominated by transgenic animal sub-segment. Key players operating in the global animal biotechnology market are Heska Corporation, Indian Immunologicals Ltd. Major players are focusing on new product launches, acquisitions, and geographical expansion to increase their market share in the lucrative animal biotechnology market.

Engineering Life: Synthetic Biology and the Future of Biotechnology

Anjali Pawar 2023-05-30

This emerging field holds immense potential for transforming various industries and shaping the future of biotechnology. Through synthetic biology, researchers can design and construct genetic circuits, biological systems, and even entirely new organisms with customized functionalities. By modifying and optimizing Biotechnology processes, synthetic biology offers opportunities for the development of renewable energy sources, the creation of eco-friendly manufacturing processes, and the production of novel biomaterials with unique properties. As synthetic biology continues to advance, it holds the potential to revolutionize industries, accelerate scientific breakthroughs, and address pressing global challenges, shaping a future where engineered life plays a central role in biotechnological advancements. By harnessing the power of biotechnology, personalized medicine offers the potential to revolutionize healthcare, improving patient outcomes, and transforming the way we approach disease prevention and treatment.

The global Red Biotechnology Market Growth Accelerated by Increasing Adoption of Personalized Medicine

naufan003 2023-12-22

The global Red Biotechnology Market is estimated to be valued at US$ 742. Segment Analysis Red Biotechnology Market is segmented by technology into gene therapy, immunotherapy, regenerative medicine, and others. Key Takeaways The Global Red Biotechnology Market Size is expected to witness high growth during the forecast period of 2023 to 2030. Key players Key players operating in the Red Biotechnology market are Amgen, Gilead Sciences, Biogen, Pfizer, Novartis, Roche, Johnson & Johnson, Sanofi, Merck & Co. Partnership and collaboration with research institutes are also among the strategies adopted by companies to expand their presence in the red biotechnology market.

The Global Biotechnology Market Growth Accelerated By Advancement In Gene Therapy Technologies

kiran gire 2024-01-05

The global Biotechnology Market is estimated to be valued at US$ 820. Segment Analysis The global biotechnology market is dominated by the healthcare biotechnology segment. Within healthcare biotechnology, major sub-segments include pharmaceutical biotechnology, bioservices, bioinformatics, gene therapy among others. The global Biotechnology Market is estimated to be valued at US$ 820. Regional analysis: North America currently dominates the global biotechnology market led by developed biotechnology infrastructure and presence of major players in the US and Canada. currently leads the global biotechnology drug sales, followed by Novartis AG while Roche dominated the sales of biotechnology drugs in Europe.

The Future of Immunoassay Instruments: Pioneering Technologies and Emerging Paradigms

Steve martin 2023-05-16

The future of immunoassay instruments holds immense promise, driven by pioneering technologies and emerging paradigms. Another emerging paradigm is the utilization of microfluidics in immunoassay instruments. Moreover, the integration of artificial intelligence (AI) algorithms and machine learning techniques is transforming data analysis and interpretation in immunoassay instruments. The future of immunoassay instruments also encompasses the development of multiplexed assays that can simultaneously detect multiple analytes in a single test. The future of immunoassay instruments is characterized by pioneering technologies and emerging paradigms that will revolutionize biomarker detection and analysis.

The Future of Biosimilars in Europe: Collaboration, Innovation, and Market Expansion

BioIntel360 2023-05-15

In recent years, the use of biosimilars in Europe has continued to grow, and biosimilars have become an established part of the healthcare landscape. However, they do give an indication of the significant impact that biosimilars are having on the European healthcare market. Here are some predictions for the growth of the biosimilar market in Europe:· Increased market penetration: Biosimilars have already gained significant market share in Europe, and this trend is expected to continue. As more biosimilars are developed and approved for these indications, the biosimilar market in Europe is expected to grow. Overall, BioIntel360 suggests that the biosimilar market in Europe is expected to grow, driven by increasing market penetration, expansion into new therapeutic areas, emerging markets, and innovation.

Global Tooth Regeneration Market Is Estimated To Witness High Growth Owing To Increasing Dental Implant Procedures and Technological Advancements

savi jadhav 2023-08-28

A) Market Overview:The global Tooth Regeneration Market is estimated to be valued at US$4,530. The products associated with tooth regeneration include dental implants, dental scaffolds, dental grafts, and bioactive materials. Increasing Dental Implant Procedures: The demand for tooth regeneration is driven by the rising number of dental implant procedures. Technological Advancements: Rapid advancements in regenerative dentistry and dental materials have revolutionized the Tooth Regeneration Market. Competitiveness in the dental implant marketD) Key Takeaways:- The global Tooth Regeneration Market is expected to witness high growth, exhibiting a CAGR of 5.

Unleashing Growth: Exploring the Dynamics of the Global Animal Biotechnology Market

Pratik 2024-03-29

The Global Animal Biotechnology Market is estimated to be valued at US$ 28. PEST AnalysisA PEST analysis of the Global Animal Biotechnology Market reveals several key factors influencing its dynamics. SWOT AnalysisA SWOT analysis provides insights into the strengths, weaknesses, opportunities, and threats facing the Global Animal Biotechnology Market. Segment AnalysisThe Global Animal Biotechnology Market can be segmented based on technology, application, and animal type. Geographical RegionGeographically, the Global Animal Biotechnology Market spans regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Exploring the Global Electroporation Instruments Market: Market Size, Share, and Forecast

Yashvi Gadhiya 2023-08-03

This market analysis delves into the current state of the electroporation instruments market, its size, share, and forecasted growth, shedding light on key factors that contribute to its expansion on a global scale. As of the latest Electroporation Instruments Market assessments, the electroporation instruments market has showcased substantial growth due to the increasing adoption of gene therapy and genetic research worldwide. One of the primary factors propelling Electroporation Instruments Market growth is the surging demand for efficient and safe gene delivery systems. Moreover, the Electroporation Instruments Market escalating prevalence of genetic disorders and chronic diseases has underscored the importance of gene therapy in modern healthcare. The Global Electroporation Instruments Market is anticipated to witness substantial growth, as Coherent Market Insights estimates its value to be US$ 232.

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight

Ankit Nigam 2020-10-12

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.

These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.

Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.

Global Biotechnology Services Market Analysis 2024 – Estimated Market Size And Key Drivers

Uday Kiran 2024-03-01

Learn More On The Biotechnology Services Market:https://www. The biotechnology services market size is expected to see strong growth in the next few years. Therefore, the rising pervasiveness of diseases and huge expenses on R&D are predicted to contribute to the growth of the biotechnology services market. The biotechnology services market report table of contents includes:Executive SummaryBiotechnology Services MarketCharacteristicsBiotechnology Services MarketTrends And StrategiesBiotechnology Services Market- Macro Economic ScenarioGlobal Biotechnology Services MarketSize and Growth. info/ Healthcare Blog: https://healthcareresearchreports.

Medical Robotics Is Fastest Growing Segment Fueling The Growth Of Powered Surgical Instruments Market

Lucy Kart 2023-12-11

The global powered surgical instruments market is estimated to be valued at US$ 2. Adoption of medical robotics and smart surgical devices is expected to drive the growth of powered surgical instruments market during the forecast period. Segment Analysis The global powered surgical instruments market can be segmented by product, application, end-user and region. Based on product, the powered surgical instruments market is categorized into handpieces, power sources & controls, and accessories. Key Takeaways Global Powered Surgical Instruments Market is expected to witness high growth, exhibiting CAGR of 4.

Biotechnology Market Size, Share Analysis, Key Companies, and Forecast To 2030

Namrata Waghmare 2024-03-22

The Global Biotechnology Market by 2030 Research Report is a professional and in-depth study of the current state of Biotechnology Market. BiogenCELGENE CorporationSanofiAbbottNovartis AG Get Full Details Report -Biotechnology Market Forecast To 2030@ https://www. com/market-analysis/biotechnology-market-4912 This report provides a pinpoint analysis of changing competitive dynamics. What are the key market trends impacting the growth of the Global Biotechnology Market? Reasons for Buying this Report:This report provides pin-point analysis for changing competitive dynamicsIt provides a forward looking perspective on different factors driving or restraining market growthIt provides a six-year forecast assessed on the basis of how the market is predicted to growIt helps in understanding the key product segments and their futureIt provides pin point analysis of changing competition dynamics and keeps you ahead of competitorsIt helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segmentsTABLE OF CONTENT:Table of Contents: Biotechnology Market• Part 1: Overview of Biotechnology Market• Part 2: Biotechnology Carts: Global Market Status and Forecast by Regions• Part 3: Global Market Status and Forecast by Types • Part 4: Global Market Status and Forecast by Downstream Industry• Part 5: Market Driving Factor Analysis• Part 6: Market Competition Status by Major Manufacturers• Part 7: Major Manufacturers Introduction and Market Data• Part 8: Upstream and Downstream Market Analysis• Part 9: Cost and Gross Margin Analysis• Part 10: Marketing Status Analysis • Part 11: Market Report Conclusion• Part 12: Pediatric Radiology: Research Methodology and Reference View More Reports:Intelligent Process Automation MarketMarine Biotechnology MarketLip Balm MarketBody Massage Market About Us:Data Library Research is a market research company that helps to find its passion for helping brands grow, discover, and transform.

Red Biotechnology Market Growth Accelerated by Expanded Application Areas

Rajkumar cmi 2024-02-08

Unleashing Growth: Exploring the Dynamics of the Global Animal Biotechnology Market

Pratik 2024-03-29

Animal Biotechnology Market Growth Accelerated by Developing New Therapies

Ishika cmi 2024-02-09

Exploring the Global Electroporation Instruments Market: Market Size, Share, and Forecast

Yashvi Gadhiya 2023-08-03

Engineering Life: Synthetic Biology and the Future of Biotechnology

Anjali Pawar 2023-05-30

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight

Ankit Nigam 2020-10-12